GTCR Portfolio Company, Actient Pharmaceuticals, Closes Transaction to License and Acquire Specialty Products from UCB, Inc.
CHICAGO--(BUSINESS WIRE)--GTCR, one of the country's leading private equity firms, announced today that Actient Pharmaceuticals, LLC has successfully completed a transaction t
Dismiss this window Similar articles >>
 
Bookmark and Share
Transdel Pharmaceuticals Presents Phase 3 Study Data On Ketotransdel® At World Pain Congress In Montreal, Canada (Medical News Today) 03/09/2010 13:26:03: Transdel Pharmaceuticals, Inc. (OTC Bulletin Board: TDLP), a specialty pharmaceutical company focused on developing topically administered products using its proprietary tran
LIC housing fin applies for license to PFRDA (Business Standard) 06/09/2010 09:52:00: LIC housing finance has applied for a license with the Pension Fund Regulatory Authority (PFRDA) to act as an aggregator under the National Pension System (NPS)- Lite, the com
EPE's share in portfolio (Yorkshire Post) 31/08/2010 22:33:59: PRIVATE equity company EPE Special Opportunities yesterday acquired a majority interest in a portfolio of private equity investments in a £22m reverse takeover.
KEC Intl to acquire SAE Towers (Deccan Herald) 07/09/2010 21:30:11: Briefing reporters, Chairman Harsh Goenka said the Board (of KEC International) approved the proposal this morning to acquire US-based SAE Towers Holdings, a limited liability